Varian Slips on Outlook
Varian Medical Systems (VAR) sank 3% late Wednesday after offering soft second-quarter guidance.
The news came as the company reported strong quarterly earnings and raised its full-year guidance, citing strong demand for its medical equipment.
The Palo Alto, Calif.-based manufacturer earned $50 million, or 37 cents a share, in its fiscal first quarter, up from of $41 million, or 30 cents a share, a year ago. Analysts surveyed by Thomson First Call were expecting Varian to earn 36 cents a share.
Revenue reached $388 million for the quarter, up 16% from the year-ago period. Revenue from its oncology systems totaled $316 million, up 15% from a year ago. X-ray product revenue was $62 million, 19% higher than the year-ago quarter. Analysts were expecting overall revenue of $382.15 million."This quarter was highlighted by strong growth in net orders for image-guided radiotherapy and stereotactic radiosurgery products in North America and for flat-panel digital image detectors for filmless X-rays," said Timothy Guertin, president and CEO of Varian Medical Systems, in a press release after the close of trading Wednesday. For the full year, Varian expects revenue to grow 13%, with 7% to 9% growth in its second quarter. The company's 2007 earnings should be between $1.89 and $1.91 a share, with second quarter earnings at around 46 cents a share, excluding the impact of Varian's intended acquisition of Accel Instruments. Analysts were looking for 48 cents for the quarter and $1.87 for the year. Shares dropped $1.70 late Wednesday to $48.44.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV